The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation - de,L.J.; Susce,M.T.; Pan,R.M.; Fairchild,M.; Koch,W.H.; Wedlund,P.J. (J Clin Psychiatry, 2005)